Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|December 6, 2023
ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case ReportLuis F Gonzalez-Mosquera, Fawzi Abu Rous, Alexandra Rogers, et al.
JTO Clinical and Research Reports|November 21, 2022
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189Shirish Gadgeel, Jhanelle E Gray, Maria Teresa Rizzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Phase I study of bryostatin 1 and gemcitabineBasil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.
Investigational New Drugs|July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort studyPatricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.
JTO Clinical and Research Reports|September 30, 2021
A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, RET-Rearranged NSCLCJustin F Gainor, Shirish Gadgeel, Sai-Hong I Ou, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapyShivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, et al.
JTO Clinical and Research Reports|July 26, 2022
Lung Cancer Screening Criteria and Cardiopulmonary ComorbiditiesChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.
Cancers|October 16, 2024
BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung CancerShivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, et al.
JTO Clinical and Research Reports|April 7, 2023
Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the LungFawzi Abu Rous, Pin Li, Shannon Carskadon, et al.
Pageof 11